Clinical Trials | November 24, 2025
Bayer’s experimental stroke drug could reshape secondary stroke prevention
Millions of stroke survivors across the world may soon have a new defense
Millions of stroke survivors across the world may soon have a new defense
Paxton alleges the companies marketed Plavix as a reliable defense against heart attacks, strokes, and blood clots while failing to disclose evidence that the drug could be ineffective or virtually useless for many people
These initiatives will harness top scientific talent and advanced AI technologies to develop new ways to slow the rise of drug-resistant infections
_256_384.png)
Over 700 exhibitors from APAC, Europe, the US, and beyond showcased the latest in personal care innovation
Under the agreement, Evonik will distribute InVitria’s blood-free rHSA portfolio to its biopharma customers
Stivarga is the standard third-line treatment for metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma
The new shadow roll-on delivers strong on-shelf presence with its modern rounded-base design
Nearly 1 in 3 HbA1c test results fall within the diabetic range, while 1 in 4 individuals show signs of prediabetes
The inclusion of broad-spectrum sunscreen in the WHO EML and EMLc follows an application submitted in November 2024 by the Global Albinism Alliance
VLA1601 is a purified and inactivated vaccine specifically designed to protect against the Zika virus
Subscribe To Our Newsletter & Stay Updated
